Network pharmacology identified key osteoporosis-related targets involved in inflammatory signaling, hormone regulation, and bone remodeling, with key hubs including IL-6, STAT3, NF-κB, and PPARγ. This evidence concerns the gene NFKB1 and osteoporosis.